• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Exploring New Combination Strategy of Lipid-Lowering Therapies for Primary Prevention of Cardiovascular Disease.探索用于心血管疾病一级预防的降脂治疗新联合策略。
Korean Circ J. 2024 Sep;54(9):545-548. doi: 10.4070/kcj.2024.0195.
2
A Clinical Guide to Combination Lipid-Lowering Therapy.《联合降脂治疗临床指南》
Curr Atheroscler Rep. 2018 Mar 7;20(4):19. doi: 10.1007/s11883-018-0721-2.
3
Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis.更强化的降脂治疗对心血管疾病的疗效：系统评价和荟萃分析。
BMC Cardiovasc Disord. 2020 Jul 13;20(1):334. doi: 10.1186/s12872-020-01567-1.
4
Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study.探索英国处方医生对新型降脂药物处方的认知与行为：一项定性研究。
Pharmacy (Basel). 2024 Jul 3;12(4):104. doi: 10.3390/pharmacy12040104.
5
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.固定剂量联合治疗与不联合阿司匹林用于心血管疾病一级预防的疗效：一项个体参与者数据荟萃分析。
Lancet. 2021 Sep 25;398(10306):1133-1146. doi: 10.1016/S0140-6736(21)01827-4. Epub 2021 Aug 29.
6
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies.脂质修饰干预的多效性：探索传统和新型降血脂疗法
Metabolites. 2024 Jul 17;14(7):388. doi: 10.3390/metabo14070388.
7
Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.比较欧洲和美国指南中的降脂治疗方案在心血管疾病一级预防中的应用。
Eur J Prev Cardiol. 2023 Nov 30;30(17):1856-1864. doi: 10.1093/eurjpc/zwad193.
8
Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: a systematic review and meta-analysis.急性冠脉综合征患者强化降脂治疗的获益：系统评价和荟萃分析。
Ann Med. 2024 Dec;56(1):2389470. doi: 10.1080/07853890.2024.2389470. Epub 2024 Aug 10.
9
Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.高胆固醇血症的管理、高心血管风险患者治疗方法的适宜性及新药
High Blood Press Cardiovasc Prev. 2016 Sep;23(3):217-30. doi: 10.1007/s40292-016-0155-2. Epub 2016 Aug 27.
10
Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?联合降压降脂治疗对认知功能的影响：一种新的治疗策略？
Cardiol Res Pract. 2020 Apr 14;2020:1484357. doi: 10.1155/2020/1484357. eCollection 2020.

本文引用的文献

1
Comparison of Statin With Ezetimibe Combination Therapy Versus Statin Monotherapy for Primary Prevention in Middle-Aged Adults.他汀类药物与依折麦布联合治疗与他汀类药物单药治疗对中年成年人一级预防效果的比较
Korean Circ J. 2024 Sep;54(9):534-544. doi: 10.4070/kcj.2024.0036. Epub 2024 May 30.
2
Changes in Risk Factor Status and Risk of Future ASCVD Events in Primary Prevention.一级预防中危险因素状态的变化与未来动脉粥样硬化性心血管疾病（ASCVD）事件的风险
Korean Circ J. 2024 Jun;54(6):354-356. doi: 10.4070/kcj.2024.0020. Epub 2024 Apr 11.
3
Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study.低或中强度他汀类药物联合依折麦布与高强度他汀类药物单药治疗在心血管疾病和全因死亡一级预防中的比较：一项倾向评分匹配的全国性队列研究。
Eur J Prev Cardiol. 2024 Aug 9;31(10):1205-1213. doi: 10.1093/eurjpc/zwae081.
4
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.贝匹地酸用于他汀类药物不耐受患者的心血管事件一级预防。
JAMA. 2023 Jul 11;330(2):131-140. doi: 10.1001/jama.2023.9696.
5
Statins and Clinical Outcomes in Patients With Low to Moderate Risk but With Non-obstructive Carotid Plaques: The SCOPE-CP Study.低至中度风险但伴有非阻塞性颈动脉斑块患者使用他汀类药物与临床结局：SCOPE-CP研究
Korean Circ J. 2022 Dec;52(12):890-900. doi: 10.4070/kcj.2022.0154.
6
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.用于成年人心血管疾病一级预防的他汀类药物：美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2022 Aug 23;328(8):754-771. doi: 10.1001/jama.2022.12138.
7
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.依折麦布降脂预防 75 岁及以上动脉粥样硬化性心血管疾病试验（EWTOPIA 75）：一项随机对照试验。
Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22.
8
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.在无心血管疾病的中危人群中降低胆固醇。
N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2.
9
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.辛伐他汀联合依折麦布降低慢性肾脏病患者 LDL 胆固醇的效果（心脏和肾脏保护研究）：一项随机安慰剂对照试验。
Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.
10
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

Exploring New Combination Strategy of Lipid-Lowering Therapies for Primary Prevention of Cardiovascular Disease.

作者信息

Cho Jun Hwan, Cho Eun Jeong, Jeong Young-Hoon

机构信息

CAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.

Division of Cardiology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

出版信息

Korean Circ J. 2024 Sep;54(9):545-548. doi: 10.4070/kcj.2024.0195.

DOI:10.4070/kcj.2024.0195
PMID:39195196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11361774/
Abstract
摘要